Navigation Links
Amylin Pharmaceuticals to Webcast First Quarter Results
Date:4/15/2008

SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will webcast its Quarterly Update Conference Call for the first quarter of 2008 on Monday, April 21, 2008 at 8:30 a.m. ET/5:30 a.m. PT. Daniel M. Bradbury, Amylin's President and Chief Executive Officer, will lead the call. On the same date pre-market, Amylin will release financial results for the first quarter of 2008.

The call will be webcast live through Amylin's corporate website and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com approximately fifteen minutes prior to the call to register, download and install any necessary audio software. For those without access to the Internet, the live call may be accessed by phone by calling (888) 536-6007 (U.S./Canada) or (706) 758-4632 (international), Conference ID# 43245695. A replay of the call will also be available by phone for 24 hours beginning approximately one hour after the close of the call and can be accessed at (800) 642-1687 (U.S./Canada) or (706) 645-9291 (international), Conference ID# 43245695.

About Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Di
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...EW YORK, May 9 /- Pulmo Bio...ay that it has increased its stake in,PulmoScience...this Company,which owns a unique Molecular Imaging...l conditions., Pulmo BioTech CEO Garry McCann sai...ogy, developed and owned by PulmoScience, will dom...
(Date:5/9/2008)...RISBANE, Calif., May 9 /- I...at Dan Welch, President and Chief,Executive Office...a 2008,Health Care Conference in Las Vegas on May ...cess a live audio webcast of the presentation, inv...the investor relations page of InterMune,s,corpora...
(Date:5/9/2008)...ient Group campaigns receive two gold awards and o...ides in healthcare marketing, WEST CONSHOHOCKEN, ...ier strategic interactive marketing agency serving...ved two gold and one silver Aster Awards,-- which ...rketing,professionals for outstanding excellence i...
(Date:5/9/2008)...90% of the 96 Core Curriculum Sessions Include Pre... to Magnetic Navigation Stereotaxis to Feature N... Generation Software Products in Booth 304, ...taxis, Inc. (Nasdaq:,STXS) announced today that it...broad market leadership it has achieved as the onl...
Breaking Biology Technology:Pulmo BioTech Announces an Increase in its Stake in PulmoScience 2Pulmo BioTech Announces an Increase in its Stake in PulmoScience 3Cadient Group Brings Home the Gold at 2008 Aster Awards 2Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 2Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 3Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 4Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008 5
... Wis . -- Spectrum Equity Investors of Boston will... Mortgagebot , a national provider of technology t...ounced that it has completed an $84 million recapi...ction, Michael Kennealy and Benjamin Spero from Sp... Terms of the transaction were not disclosed. , ,"...
... -- Metavante Corp., the financial technology subs...INK2GOV Corp . of Nashville, Tenn., The company wi... and will become a subsidiary of Metavante , with..., the company announced Monday. Terms of the trans...ustomized online phone and point-of-sale payment p...
...is. -- The WiCell Research Institute,s announceme...our-year, $16 million federal contract to create t...n of respect for the state,s pioneering and innova..., in the face of continued Wisconsin legislative o...h forward is anything but simple. , ,Embryonic st...
... Wis. -- Guess which news item is out of step wit...world? , ,• The state of Wisconsin grants $1 ...formed by Dr. James Thomson, a UW-Madison research...cally circle his head. The company has technology ... The National Institutes of Health, the federal go...
Other Biology Technology:Boston equity firm becomes majority owner of Cedarburg-based Mortgagebot 2Metavante acquiring LINK2Gov 2WiCell to host new national stem cell bank 2WiCell to host new national stem cell bank 3WiCell to host new national stem cell bank 4Stem cell bank announcement validates quality of Wisconsin research 2Stem cell bank announcement validates quality of Wisconsin research 3
(Date:5/9/2008)... the duck-billed platypus was published today by a...s about how genomes were organized during the earl... in part by the National Human Genome Research Ins... Health (NIH). , Fans of TV nature shows will r...ustralia, is one of the few mammals that lays eggs...
(Date:5/9/2008)... worlds largest autism advocacy organization annou...boration with North, South and Central America. Th...reness and develop research expertise focusing on ...d enhanced service delivery across the Americas. ,... with countries that have different cultures, leve...
(Date:5/9/2008)... share of grants totalling over 1m to target lung ...lan Bates, a senior lecturer in the Department of ...recipient of 1,068,000 in the form of just two res...l Sciences Research Council (EPSRC) and the other ...earch Council (BBSRC). , The grants are shared b...
(Date:5/8/2008)...(UM) students have received prestigious Graduate R...dation (NSF) for their doctoral work on coral reef...receive three years of support for their work in t...ofessor in the Division of Marine Biology and Fish...pheric Science. In addition, a third student ente...
Breaking Biology News(10 mins):Duck-billed platypus genome sequence published 2Duck-billed platypus genome sequence published 3Duck-billed platypus genome sequence published 4Autism Speaks announces multinational initiative 2Engineer to spearhead research into cell metabolism and medical injuries 2Everything's coming up corals 2Everything's coming up corals 3 Space Radiation a Risk for Astronauts 16893 1 Space Radiation a Risk for Astronauts 16893 2Nanodrop test tubes created with a flip of a switch 2902 1Nanodrop test tubes created with a flip of a switch 2902 2Annual Shareholders Meeting to Be Held May 5 2008 at the University Club in St Paul MN 16886 1Annual Shareholders Meeting to Be Held May 5 2008 at the University Club in St Paul MN 16886 2AUDIO from Medialink and Apple Products Research and Education Council 3A New Research Adults Who Eat Apples Apple Juice Have Healthier Diets and 16881 1
... at the Université de Montréal has concluded that ...t or a night of studying will strongly hurt their ...n the current issue of Neuropsychopharmacology was...t of Psychology at the Université de Montréal. Dr....Hôpital du Sacré-Coeur de Montréal. , "We already...
...looks like something out of an old science fiction... Center in Chicago say it holds promise in the tre...stem, developed by Actuality Systems, Inc., create...ll-color, full-motion system can display images of...n true 3D space. , A study led by Rush, which a...
... led by a University of Utah medicinal chemist hav...r and other diseases from bacteria found in sponge...ublished Sunday, Nov. 5, in Nature Chemical Biolog...that live only in sea squirts and other marine lif...lth of chemicals, which accumulate in the tissues ...
...nding of the evolutionary dynamics of the influenz...d control the virus. In a new study, published onl... Eddie C. Holmes of the Department of Biology at P... National Institutes of Health, the Wordsworth Cen...nomic analysis to investigate the evolutionary pro...
Other Biology News:Negative effects of caffeine are stronger on daytime sleep than on nocturnal sleep 2Preliminary study finds holographic imaging system promising for cancer treatment planning 2Bacteria in small sea life yield new way to make potential cancer drugs 2
ASCIZ
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C
Chaps Cell Extract Buffer can be used to lyse cells under nondenaturing conditions and is recommendedfor the preparation of cell lysates to be used with our caspase signaling pathway antibodies
Rabbit polyclonal to Reptin/TIP49B/RUVB2 ( Abpromise for all tested applications). Antigen: Synthetic peptide (Human) Entrez Gene ID: 10856 Swiss Protein ID: Q6FIB9
Biology Products: